These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3674788)

  • 41. Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder.
    Seraj MJ; Thomas AR; Chin JL; Theodorescu D
    Clin Cancer Res; 2001 Jun; 7(6):1516-22. PubMed ID: 11410485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy.
    Wiesner C; Pfitzenmaier J; Faldum A; Gillitzer R; Melchior SW; Thüroff JW
    BJU Int; 2005 Feb; 95(3):301-5. PubMed ID: 15679782
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients.
    Zaghloul MS; Nouh A; Nazmy M; Ramzy S; Zaghloul AS; Sedira MA; Khalil E
    Urol Oncol; 2006; 24(1):13-20. PubMed ID: 16414487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis.
    Abdel-Latif M; Abol-Enein H; El-Baz M; Ghoneim MA
    J Urol; 2004 Jul; 172(1):85-9. PubMed ID: 15201743
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radical cystectomy for invasive bladder cancer--a local experience.
    Abratt RP; Shepherd LC; Pontin AR; Barnes RD; Ball HS
    S Afr J Surg; 1998 Aug; 36(3):87-9; discussion 89-90. PubMed ID: 9810218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The evolving role of pelvic lymphadenectomy in the treatment of bladder cancer.
    Sanderson KM; Stein JP; Skinner DG
    Urol Oncol; 2004; 22(3):205-11; discussion 212-3. PubMed ID: 15271318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prognostic value of lymphatic metastasis in bladder cancer].
    Martínez-Piñeiro L; Madrid J; Julve E; García Cardoso JV; Ortega L; de la Peña J; Martínez-Piñeiro JA
    Arch Esp Urol; 1997 May; 50(4):365-71. PubMed ID: 9313045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical study on recurrence in bladder cancer patients undergoing total cystectomy--statistical analysis of factors related to recurrence.
    Honda N; Yamada Y; Mitsui K; Mizumoto H; Taki T; Kamijyo A; Okada M; Hibi H; Fukatsu H
    Hinyokika Kiyo; 1999 May; 45(5):317-24. PubMed ID: 10410313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy.
    Leissner J; Koeppen C; Wolf HK
    J Urol; 2003 Mar; 169(3):955-60. PubMed ID: 12576821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.
    Kassouf W; Agarwal PK; Herr HW; Munsell MF; Spiess PE; Brown GA; Pisters L; Grossman HB; Dinney CP; Kamat AM
    J Clin Oncol; 2008 Jan; 26(1):121-6. PubMed ID: 18165646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Radical cystectomy for superficial tumors in the BCG era].
    Huguet Pérez J; Palou J; Millán Rodríguez F; Villavicencio Mavrich H; Rodríguez JV
    Arch Esp Urol; 2002; 55(1):50-6. PubMed ID: 11957752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary invasive versus progressive invasive transitional cell bladder cancer: multicentric study of overall survival rate.
    Ferreira U; Matheus WE; Nardi Pedro R; Levi D'Ancona CA; Reis LO; Stopiglia RM; Denardi F; Rodrigues Netto N; de Cássio Zequi S; da Fonseca FP; Lopes A; Cardoso Guimarães G; de Carvalho Fernandes R; Cardenuto Perez MD
    Urol Int; 2007; 79(3):200-3. PubMed ID: 17940350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cystectomy in the management of bladder cancer].
    Kondás J; Szentgyörgyi E; Diószeghy G; Váczi L; Kiss A
    Orv Hetil; 1994 Jan; 135(3):119-24. PubMed ID: 7507227
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Superiority of ratio based lymph node staging for bladder cancer.
    Herr HW
    J Urol; 2003 Mar; 169(3):943-5. PubMed ID: 12576818
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bladder cancer with lymph node invasion: cystectomy or no cystectomy?
    Richard F
    Prog Clin Biol Res; 1989; 303():597-602. PubMed ID: 2675014
    [No Abstract]   [Full Text] [Related]  

  • 56. Re: pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
    Neulander EZ
    J Urol; 2002 Feb; 167(2 Pt 1):651. PubMed ID: 11792943
    [No Abstract]   [Full Text] [Related]  

  • 57. Multi-modal treatment of deep infiltrating (T3) bladder cancer.
    Bloom HJ
    Prog Clin Biol Res; 1978; 25():117-34. PubMed ID: 104306
    [No Abstract]   [Full Text] [Related]  

  • 58. [Lymph node pattern and peritumoral lymphoid infiltration in cancer of the bladder. Prognostic value].
    Gamallo C; Isorna S; Marrón C; Ortas J; Martínez-Piñeiro JA; Contreras F
    Arch Esp Urol; 1978; 31(1):11-26. PubMed ID: 697410
    [No Abstract]   [Full Text] [Related]  

  • 59. Re: preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer. C. J. Stimson, M. S. Cookson, D. A. Barocas, P. E. Clark, J. E. Humphrey, S. G. Patel, J. A. Smith, Jr. and S. S. Chang. J Urol 2010; 183: 1732-1737.
    Neulander EZ; Katz T; Yusim I; Kaneti J
    J Urol; 2011 Apr; 185(4):1536-7. PubMed ID: 21334665
    [No Abstract]   [Full Text] [Related]  

  • 60. Validation of the urostomy education scale: the European experience.
    Jensen BT; de Blok W; Kiesbye B; Kristensen SA
    Urol Nurs; 2013; 33(5):219-29. PubMed ID: 24354110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.